Fortis Group Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $335 | Hold |
20
| – | – | ﹤0.01% | 494 |
|
|
2025
Q1 | $307 | Hold |
20
| – | – | ﹤0.01% | 466 |
|
|
2024
Q4 | $441 | Hold |
20
| – | – | ﹤0.01% | 469 |
|
|
2024
Q3 | $360 | Hold |
20
| – | – | ﹤0.01% | 467 |
|
|
2024
Q2 | $325 | Hold |
20
| – | – | ﹤0.01% | 471 |
|
|
2024
Q1 | $282 | Sell |
20
-20
| -50% | -$282 | ﹤0.01% | 486 |
|
|
2023
Q4 | $418 | Buy |
40
+20
| +100% | +$209 | ﹤0.01% | 427 |
|
|
2023
Q3 | $204 | Buy |
+20
| New | +$204 | ﹤0.01% | 427 |
|
|
2020
Q3 | $0 | Buy |
+20
| New | – | ﹤0.01% | 476 |
|